Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 5 | 625.00 | 303.79 | 671.00 | 675.50 | 0.9933 | 0.9884 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 5 | 625.00 | 303.79 | 595.00 | 675.50 | 0.8808 | 0.7916 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 5 | 625.00 | 303.79 | 749.00 | 675.50 | 1.1088 | 1.1875 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 5 | 625.00 | 303.79 | 776.00 | 675.50 | 1.1488 | 1.2557 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 5 | 625.00 | 303.79 | 899.00 | 675.50 | 1.3309 | 1.5627 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 5 | 625.00 | 303.79 | 725.00 | 675.50 | 1.0733 | 1.1265 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 5 | 625.00 | 303.79 | 625.00 | 675.50 | 0.9252 | 0.8697 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 5 | 625.00 | 303.79 | 915.00 | 675.50 | 1.3546 | 1.6023 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 5 | 625.00 | 303.79 | 772.00 | 675.50 | 1.1429 | 1.2456 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 5 | 625.00 | 303.79 | 727.00 | 675.50 | 1.0762 | 1.1316 |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 912.00 | 675.50 | 1.3501 | 1.5948 | |
| SK-BR-3 | Nilotinib | 0.01 | uM | 5 | 625.00 | 303.79 | 552.00 | 675.50 | 0.8172 | 0.6787 |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 727.00 | 675.50 | 1.0762 | 1.1316 | |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 5 | 625.00 | 303.79 | 740.00 | 675.50 | 1.0955 | 1.1646 |
| SK-BR-3 | Etoposide | 0.01 | uM | 5 | 625.00 | 303.79 | 726.00 | 675.50 | 1.0748 | 1.1291 |
| SK-BR-3 | Etoposide | 1 | uM | 5 | 625.00 | 303.79 | 419.00 | 675.50 | 0.6203 | 0.3217 |
| SK-BR-3 | PLX-4720 | 10 | uM | 5 | 625.00 | 303.79 | 607.00 | 675.50 | 0.8986 | 0.8229 |
| SK-BR-3 | Etoposide | 10 | uM | 5 | 625.00 | 303.79 | 403.00 | 675.50 | 0.5966 | 0.2778 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 5 | 625.00 | 303.79 | 758.00 | 675.50 | 1.1221 | 1.2102 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 5 | 625.00 | 303.79 | 598.00 | 675.50 | 0.8853 | 0.7994 |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 688.00 | 675.50 | 1.0185 | 1.0321 | |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 445.00 | 675.50 | 0.6588 | 0.3925 | |
| SK-BR-3 | 0 | uM | 5 | 1250.00 | 731.83 | 1585.00 | 1776.50 | 0.8922 | 0.8294 | |
| SK-BR-3 | 0 | uM | 5 | 1250.00 | 731.83 | 1849.00 | 1776.50 | 1.0408 | 1.0635 | |
| SK-BR-3 | Etoposide | 19.9526 | uM | 5 | 1250.00 | 731.83 | 826.00 | 1776.50 | 0.4650 | 0.0992 |